Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Drug Concentrations in the Treatment of Multidrug-resistant Tuberculosis in Relation to Minimum Inhibitory Concentrations - a Prospective Observational Study

NCT02816931 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT02816931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02816931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Drug Concentrations in the Treatment of Multidrug-resistant Tuberculosis in Relation to Minimum Inhibitory Concentrations - a Prospective Observational Study
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
March 31, 2016
Completion date
June 1, 2020
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, multidrug resistant